HROWL Projected Dividend Yield
8.625% Sr Nt 04/30/2026/Harrow Health Inc ( NASDAQ : HROWL )Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures. 13 YEAR PERFORMANCE RESULTS |
HROWL Dividend History Detail HROWL Dividend News HROWL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
Apr 03, 2024 |
Apr 12, 2024 |
Apr 15, 2024 |
Apr 30, 2024 |
0.5391 |
2024 |
Jan 03, 2024 |
Jan 11, 2024 |
Jan 15, 2024 |
Jan 31, 2024 |
0.5391 |
2024 Total: |
1.0781 |
||||
2023 |
Oct 06, 2023 |
Oct 12, 2023 |
Oct 15, 2023 |
Oct 31, 2023 |
0.5391 |
2023 |
Jul 05, 2023 |
Jul 13, 2023 |
Jul 15, 2023 |
Jul 31, 2023 |
0.5391 |
2023 |
Apr 04, 2023 |
Apr 13, 2023 |
Apr 15, 2023 |
Apr 30, 2023 |
0.5391 |
2023 |
Jan 04, 2023 |
Jan 12, 2023 |
Jan 15, 2023 |
Jan 31, 2023 |
0.5391 |
2023 Total: |
2.1562 |
||||
2022 |
Oct 04, 2022 |
Oct 13, 2022 |
Oct 15, 2022 |
Oct 31, 2022 |
0.5391 |
2022 |
Jul 05, 2022 |
Jul 14, 2022 |
Jul 15, 2022 |
Jul 31, 2022 |
0.5391 |
2022 |
Apr 05, 2022 |
Apr 13, 2022 |
Apr 15, 2022 |
Apr 30, 2022 |
0.5391 |
2022 |
Jan 04, 2022 |
Jan 13, 2022 |
Jan 15, 2022 |
Jan 31, 2022 |
0.5391 |
2022 Total: |
2.1562 |
||||
2021 |
Oct 12, 2021 |
Oct 14, 2021 |
Oct 15, 2021 |
Nov 01, 2021 |
0.5391 |
2021 |
Aug 03, 2021 |
N/A |
Jul 15, 2021 |
Aug 02, 2021 |
0.6049 |
2021 Total: |
1.1440 |